Carcinoid heart disease

Circulation

Volumn 116, Issue 24, 2007, Pages 2860-2865

  Bhattacharyya, Sanjeev ^a   Davar, Joseph ^a   Dreyfus, Gilles ^b   Caplin, Martyn E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Carcinoid heart disease; Heart diseases; Valves

Indexed keywords

DIGOXIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; THIAZIDE DIURETIC AGENT;

BIOCHEMISTRY; CARCINOID SYNDROME; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART SURGERY; HISTOLOGY; HUMAN; MORPHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEROTONIN RELEASE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

CARCINOID HEART DISEASE; ELECTROCARDIOGRAPHY; HEART VALVES; HUMANS; MAGNETIC RESONANCE IMAGING; MALIGNANT CARCINOID SYNDROME; MYOCARDIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 37349019345     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.701367     Document Type: Review

References (49)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813-829.
2. Caplin M, Buscombe J, Hilson A, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet. 1998;352:799-805.
3. Quaedvlieg P, Visser O, Lamers C, Janssen-Heijen M, Taal B. Epidemiology and survival in patients with carcinoid disease in the Netherlands. Ann Oncol. 2001;12:1295-1300.
4. Thorson A, Biorck G, Bjorkman G, Waldenstrom J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: a clinical and pathologic syndrome. Am Heart J. 1954;47:795-817.
5. Pellika PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation. 1993;87:1188-1196.
6. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E. Relationship of circulating vasoactive substances to ultrasound detectable cardiac abnormalities. Circulation. 1988;77:264-269.
7. Zuetenhorst J, Korse C, Bonfrer J, Bakker RH, Taal B. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer. 2004;90:2073-2079.
8. Chaowalit N, Connolly HM, Schaff HV, Webb MJ, Pellikka PA. Carcinoid heart disease associated with primary ovarian carcinoid tumour. Am J Cardiol. 2004;93:1314-1315.
9. Bernheim AM, Connolly HM, Pellikka PA. Carcinoid heart disease in patients without hepatic metastases. Am J Cardiol. 2007;99:292-294.
10. McGuire MR, Pugh DM, Dunn MI. Carcinoid heart disease: restrictive cardiomyopathy as a late complication. J Kans Med Soc. 1978;79:661-662.
11. Rich LL, Lisa CP, Nasser WK. Carcinoid pericarditis. Am J Med. 1973;54:522-527.
12. Blick DR, Zoghbi WA, Lawrie GM, Verani MS. Carcinoid heart disease presenting as right to left shunt and congestive heart failure: successful surgical treatment. Am Heart J. 1988;115:201-203.
13. Connolly H, Crary J, McGoon M, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluraminephentermine. N Engl J Med. 1997;337:581-588.
14. Jagroop I, Mikhailidis D. An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models. Platelets. 2000;11:161-165.
15. Waltenberger J, Lundin L, Oberg K, Willander E, Miyazono K, Heldin CH, Funa K. Involvement of transforming growth factor in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol. 1993;142:71-78.
16. Jian B, Xu J, Connolly J, Savani RC, Narula N, Liang B, Levy RJ. Serotonin mechanisms in heart valve disease, I: serotonin-induced up-regulation of transforming growth factor β1 via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol. 2002;161:2111-2121.
17. Gustafsson B, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligard E, Fossmark R, Bakke I, Syverson U, Waldum H. Long-term serotonin administration induces heart valve disease in rats. Circulation. 2005;111:1517-1522.
18. Mekontso-Dessap A, Brouri F, Pascal O, Lechat P, Hanoun N, Lanfumey L, Seif I, Benhaiem-Sigaux N, Kirsch M, Hamon M, Adnot S, Eddahibi S. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation. 2006;113:81-89.
19. Robiolio P, Rigolin V, Wilson J, Harrison K, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995;92:790-795.
20. Moller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors associated with the progression of carcinoid heart disease. N Eng J Med. 2003;348:1005-1015.
21. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H. Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest. 1991;87:1402-1412.
22. Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc. 2002;77:139-147.
23. Ferrans VJ, Roberts WC. The carcinoid endocardial plaque: an ultrastructural study. Hum Pathol. 1976;7:387-409.
24. Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1986;79:339-354.
25. Howard RJ, Drobac M, Rider WD, Keane TJ, Finlayson J, Silver MD, Wigle ED, Rakowski H. Carcinoid heart disease: diagnosis by two-dimensional echocardiography. Circulation. 1982;66:1059-1065.
26. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Eng J Med. 2007;356:39-46.
27. Ho SY, Nihoyannopoulos. Anatomy, echocardiography, and normal right ventricular dimensions. Heart. 2006;92:2-13.
28. Mansencal N, Mitry E, Forissier J, Martin F, Redheuil A, Lepere C, Farcot J, Joseph T, Lacombe P, Rougier P, Dubourg O. Assessment of patent foramen ovale in carcinoid heart disease. Am Heart J. 2006;151:1129.e1-1129.e6.
29. Connolly HM, Schaff HV, Mullany CJ, Rubin J, Abel MD, Pellikka PA. Surgical management of left sided carcinoid heart disease. Circulation. 2001;104(suppl):I-36-I-40.
30. Fishman AP, Pietra GG. Handling of bioactive materials by the lung. N Engl J Med. 1974;291:884-890.
31. Pandya UH, Pellikka PA, Enriquez-Sarano M, Edwards WD, Schaff HV, Connolly HM. Metastatic carcinoid tumour to the heart: echocardiographic pathologic study of 11 patients. J Am Coll Cardiol. 2002;40:1328-1332.
32. Lundin L, Landelius J, Andren B, Oberg K. Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease. Br Heart J. 1990;64:190-194.
33. Bastarrika G, Cao MG, Cano D, Barba J, Saenz de Buruaga JD. Magnetic resonance imaging diagnosis of carcinoid heart disease. J Comput Assist Tomogr. 2005;29:756-759.
34. Mollet NR, Dymarkowski S, Bogaert J. MRI and CT revealing carcinoid heart disease. Eur Radiol. 2003;13:L14-L18.
35. Grant SC, Scarffe JH, Levy RD, Brooks NH. Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis. Br Heart J. 1992;67:450-453.
36. Onate A, Alchibar J, Inguanzo R, Peria N, Gochi R. Balloon dilatation of tricuspid and pulmonary valves in carcinoid heart disease. Texas Heart Inst J. 1993;20:115-119.
37. Hargreaves AD, Pringle SD, Boon NA. Successful balloon dilatation of the pulmonary valve in carcinoid heart disease. Int J Cardiol. 1994;45:150-151.
38. Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols LK. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol. 1995;25:410-416.
39. Moller JE, Pellikka PA, Bernheim AM, Schaff HV, Rubin J, Connolly HM. Prognosis of carcinoid heart disease: an analysis of 200 cases over two decades. Circulation. 2005;112:3320-3327.
40. Connolly HM, Schaff HV, Mullany CJ, Abel MD, Pellikka PA. Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling. Circulation. 2002;106:51-56.
41. Ridker PM, Chertow GW, Karlson EW, Neish AS, Schoen FJ. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J. 1991;121:1835-1838.
42. Ohri SK, Schofield JB, Hodgson H, Oakley CM, Keogh BE. Carcinoid heart disease: early failure of an allograft valve replacement. Ann Thorac Surg. 1994;67:450-453.
43. McDonald ML, Nagorney DM, Connolly HM, Nishimura RA, Schaff HV. Carcinoid and carcinoid syndrome: successful surgical treatment. Ann Thorac Surg. 1999;67:537-539.
44. Thorburn CW, Morgan JJ, Shanahan MX, Chang VP. Long term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. Am J Cardiol. 1983;51:1128-1132.
45. Boglioli LR, Gardiner J, Gerstenblith G, Taff ML, Cameron DE. Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale. Tex Heart Inst J. 1997;24:125-128.
46. Marenco J, Naimi S, Hijazi Z, Patel A, Pandian N. Non-surgical closure of a PFO in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting. Catheter Cardiovasc Interv. 2000;51:210-213.
47. Marsh HM, Martin KJ, Kvols LK, Gracey DR, Warner MA, Warner ME, Moertel CG. Carcinoid crises during anesthesia: successful treatment with a somatostatin analogue. Anesthesiology. 1987;66:89-91.
48. Claure RE, Drover DD, Haddow GR, Esquivel CO, Angst MS. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anaesthetic management. Can J Anaesth. 2000;47:334-337.
49. Ockert DB, White RD. Anesthetic management of patients with carcinoid heart disease undergoing cardiac surgery: two case reports and a review of previous experience. J Cardiothorac Vasc Anesth. 1988;2:658-665.